Skip to content
MytoHealth
  • Our Science
    • Mitochondria
  • Our Mission
    • Mitophagy and Mitoboigenesis
    • Ubiquitin Proteasome System
  • Products
    • Nutraceuticals
    • Pharmaceuticals
    • Muscle Health
    • Healthy Aging
  • Services
    • Neurodegenerative Biomarkers
    • Parkinson’s Disease Biomarkers
    • Personalized Medicine
    • AI for Neuronal Health
  • Working with Myto Health
    • Business Development
    • Tools and probes
    • Academic Collaborations
    • Technology sharing
  • News
    • Launch of MytoHealth
    • Publications
    • Blogs
    • Articles
  • About
    • Contact
    • FAQ
MytoHealth
Menu
  • Our Science
    • Mitochondria
  • Our Mission
    • Mitophagy and Mitoboigenesis
    • Ubiquitin Proteasome System
  • Products
    • Nutraceuticals
    • Pharmaceuticals
    • Muscle Health
    • Healthy Aging
  • Services
    • Neurodegenerative Biomarkers
    • Parkinson’s Disease Biomarkers
    • Personalized Medicine
    • AI for Neuronal Health
  • Working with Myto Health
    • Business Development
    • Tools and probes
    • Academic Collaborations
    • Technology sharing
  • News
    • Launch of MytoHealth
    • Publications
    • Blogs
    • Articles
  • About
    • Contact
    • FAQ

Key Publications

Age on Autophagy, Mitophagy and Lysosomes in Skeletal Muscle

The Ubiquitin Proteasome System as a Therapeutic Area in Parkinson’s Disease

Pleiotropic Effects of Mitochondria in Aging

E3 Overexpression Protects from Ageing-Related Loss of Muscle Mass and Strength

Assessment of heterogeneity in Parkinson’s Progression Markers Initiative cohort using α-synuclein seed amplification

Molecular Basis for the Therapeutic Effects of Exercise on Mitochondrial Defects

Potent and selective covalent inhibition of the papain-like protease from SARS-CoV-2

Products

Parkinson’s Disease Biomarkers

Business Development

Contact us

Copyright © 2025 MytoHealth